share_log

Earnings Grew Faster Than the 6.2% CAGR Delivered to Impulse (Qingdao) Health TechLtd (SZSE:002899) Shareholders Over the Last Three Years

Earnings Grew Faster Than the 6.2% CAGR Delivered to Impulse (Qingdao) Health TechLtd (SZSE:002899) Shareholders Over the Last Three Years

收益增長速度快於過去三年向衝動(青島)健康科技有限公司 (SZSE:002899) 的股東提供的6.2%年複合增長率
Simply Wall St ·  10/23 19:52

It's been a soft week for Impulse (Qingdao) Health Tech Co.,Ltd. (SZSE:002899) shares, which are down 14%. But don't let that distract from the very nice return generated over three years. After all, the share price is up a market-beating 18% in that time.

對於青島心浪健康科技有限公司(SZSE:002899)的股票來說,這是一個疲軟的一週,下跌了14%。 但不要因此而忽視過去三年中創造的非常不錯的回報。 畢竟,股價在這段時間內上漲了超過市場18%。

In light of the stock dropping 14% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive three-year return.

鑑於股票在過去一週下跌了14%,我們想調查長期圖片,並查看基本面是否是公司三年回報的驅動力。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

在他的《格雷厄姆和道德斯維爾的超級投資者》一文中,禾倫·巴菲特描述了股價並不總是合理反映企業價值的方法。檢驗市場情緒如何隨時間變化的一種方法是觀察公司股價和每股收益(EPS)之間的互動關係。

During three years of share price growth, Impulse (Qingdao) Health TechLtd achieved compound earnings per share growth of 25% per year. The average annual share price increase of 6% is actually lower than the EPS growth. Therefore, it seems the market has moderated its expectations for growth, somewhat.

在三年的股價增長期間,青島心浪健康科技有限公司實現了每年25%的複合每股收益增長。 平均每年6%的股價增長實際低於每股收益的增長。 因此,市場似乎已經適度降低了對增長的預期。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(隨時間的推移)如下圖所示(單擊可查看確切數字)。

big
SZSE:002899 Earnings Per Share Growth October 23rd 2024
深證:002899每股收益增長2024年10月23日

It might be well worthwhile taking a look at our free report on Impulse (Qingdao) Health TechLtd's earnings, revenue and cash flow.

值得一看的是我們對沖動(青島)醫療科技有限公司的收益、營業收入和現金流的免費報告。

A Different Perspective

不同的觀點

Impulse (Qingdao) Health TechLtd shareholders gained a total return of 5.8% during the year. Unfortunately this falls short of the market return. On the bright side, that's still a gain, and it's actually better than the average return of 3% over half a decade This could indicate that the company is winning over new investors, as it pursues its strategy. It's always interesting to track share price performance over the longer term. But to understand Impulse (Qingdao) Health TechLtd better, we need to consider many other factors. Case in point: We've spotted 1 warning sign for Impulse (Qingdao) Health TechLtd you should be aware of.

衝動(青島)醫療科技有限公司的股東在一年內總回報爲5.8%。不幸的是,這低於市場回報。然而,在光明的一面,這仍然是一筆收益,實際上比半個世紀以來的3%的平均回報更好。這可能表明公司正在贏得新投資者的青睞,因爲它實施其策略。長期追蹤股價表現總是很有趣。但要更好地了解衝動(青島)醫療科技有限公司,我們需要考慮許多其他因素。例如:我們發現了1個衝動(青島)醫療科技有限公司的警告標誌,您應該注意。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

當然,您可能在其他地方找到一家出色的企業進行投資。因此,請查看我們預計將實現盈利增長的公司的免費列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論